Scientists from China’s Tianjin University have made a groundbreaking discovery in the fight against Alzheimer's disease (AD). A new nanomedicine, known as TQCN, has been developed, showing great potential in combating the pathophysiological consequences of AD by targeting a process called ferroptosis, which plays a vital role in the progression of the disease.
Keep reading with a 7-day free trial
Subscribe to China Academy Newsletter to keep reading this post and get 7 days of free access to the full post archives.